Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens

European Journal of Immunology

Volumn 29, Issue 9, 1999, Pages 2826-2834

  Livingstone, Alexandra M ^a,b,c   Kühn, Marina ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

CTL; Dendritic cell; Help

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HELPER CELL; HISTOCOMPATIBILITY GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033370170     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199909)29:09<2826::AID-IMMU2826>3.0.CO;2-M     Document Type: Article

References (41)

1. Keene, J. and Forman, J., Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 1982.155: 768-782.
2. Simpson, E. and Gordon, R., Responsiveness to HY antigen: Ir gene complementation and target cell specificity. Immunol. Rev. 1977. 35: 59-75.
3. von Boehmer, H. and Haas, W., Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen. J. Exp. Med. 1979.150:1134-1142.
4. Keene, J. and Forman, J., Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 1982.155: 768-782.
5. Rees, M., Rosenberg, A., Munitz, T. and Singer, A., In vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T cell help. Proc. Nail. Acad. Sei. USA 1990. 87: 2765-2769.
6. Guerder, S. and Matzinger, P., A fail-safe mechanism for maintaining self-tolerance/J. Exp. Med. 1992. 176: 553-564.
7. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 1988.62:2102-2106.
8. Bodmer, H., Obert, G., Chan, S., Benoist, C. and Mathis, D., Environmental modulation of the autonomy of cytotoxic T lymphocytes. Eur. J. Immunol. 1993. 23: 1649-1654.
9. Tripp, R., Sarawar, S. and Doherty, P., Characteristics of the influenza virus-specific CDS T cell response in mice homozygous for disruption of the H-2IAb gene. J. Immunol. 1995.155: 2955-2959.
10. von Herrath, M., Yokoyama, M., Docktor, J., Oldstone, M. and Whitton, J., CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol. 1996. 70:1072-1079.
11. + T cells. J. Exp. Med. 1996.184:863-871.
12. Bennett, S., Carbone, F., Karamalis, F., Miller, J. and Heath, W. R., Induction of a CDS cytotoxic T lymphocyte response by cross-priming requires cognate CD4 help. J. Exp. Med. 1997.186: 65-70.
13. Mitchison, N. and O'Malley, C., Three-cell clusters of T cells with antigen presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur. J. Immunol. 1987. 17: 1579-1583.
14. + T-helper cell and a T-killer cell. Nature 1998. 393: 474-478.
15. Bennett, S., Carbone, F., Karamalis, F., Flavell, R., Miller, J. and Heath, W., Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998. 393: 478-480.
16. Schoenberger, S., Toes, R., van der Voort, E., Offringa, R. and Melief, C., T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998. 393: 480-483.
17. Lanzavecchia, A., Licence to kill. Nature 1998. 393: 413-414.
18. Norbury, C., Chambers, B., Prescott, A., Ljunggren, H.-G. and Watts, C., Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow derived dendritic cells. Eur. J. Immunol. 1997.27:280-288.
19. Buller, R., Holmes, K., Hügin, A., Frederickson, T. and Morse III, H., Induction of cytotoxic T cell responses in vivo in the absence of CD4 helper T cells. Nature 1987.328:77-79.
20. Hou, S., Mo, X., Hyland, L. and Doherty, P., Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins. J. Virol. 1995. 69:1429-1434.
21. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colonystimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994.179: 1109-1118.
22. Takahashi, H., Nakagawa, Y., Yokomuro, K. and Berzofsky, J., Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunol. 1993.5:849-857.
23. Porgador, A. and Gilboa, E., Bone marrow-generated dendritic cells pulsed with a class l-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 1995. 192: 255-260.
24. Celluzzi, C., Mayordomo, J., Storkus, W., Lotze, M. and Falo, L., Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 1996.183: 283-287.
25. Zitvogel, L, Majordomo, J., Tjandrawan, T., DeLeo, A., Clarke, M., Lotze, M. and Storkus, W., Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 1996. 183: 87-97.
26. Mayordomo, J., Zorina, T., Storkus, W., Zitvogel, L, Celluzzi, C., Falo, L., Melief, C., lldstad, S., Käst, W., DeLeo, A. and Lotze, M., Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1995.1:1297-1302.
27. Ludewig, B., Ehl, S., Karrer, U., Odermatt, B., Hengartner, H. and Zinkernagel, R., Dendritic cells efficiently induce protective antiviral immunity. J. Virol. 1998.72:3812-3818.
28. Young, J. and Inaba, K., Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 1996.183: 7-11.
29. Moore, M., Carbone, F. and Bevan, M., Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988. 54: 777-785.
30. Boog, C., Boes, J. and Melief, C., Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses. Eur. J. Immunol. 1988.18: 219-223.
31. Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C. and Mathis, D., Mice lacking MHC class II molecules. Cell 1991. 66:1051-1066.
32. Bailey, D. and Mobraaten, L., Estimates of the number of loci contributing to the histocompatibility between C57BL/6 and BALB/c strains of mice. Transplantation 1969.7:394-400.
33. Bailey, D., Genetics of histocompatibility in mice. I. New loci and congenic lines. Immunogenetics 1975. 2: 249-256.
34. Königen, F., Süss, G., Stewart, C., Steinmetz, M. and Bluethmann, H., Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 1993. 5: 957-964.
35. Crowley, M., Inaba, K., Witmer-Pack, M. and Steinman, R., The cell surface of mouse dendritic cells: FACS analysis of dendritic cells from different tissues including thymus. Cell. Immunol. 1989.118:108-125.
36. Wettstein, P. and Bailey, D., Immunodominance in the immune response to "multiple" histocompatibility antigens. Immunogenetics 1982.16: 47-58.
37. Wettstein, P., Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. II. Observations of a hierarchy among dominant antigens. Immunogenetics 1986. 24: 24-31.
38. Hill, A., Müllbacher, A. and Blanden, Ft., Ir genes, peripheral cross-tolerance and immunodominance in MHC class l-restricted T-cell responses: an old quagmire revisited. Immunol. Rev. 1993.133: 75-91.
39. Rock, K. and Clark, K., Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous anttg'en-MHC class I presentation pathway. J. Immunol. 1996.156:3721-3726.
40. Karasuyama, H. and Melchers, F., Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 1988.18: 97-104.
41. Matzinger, P., The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Methods 1991.145:185-192.